FDA Inspection 1224388 — Madrigal Pharmaceutical, Inc
The FDA completed an inspection of Madrigal Pharmaceutical, Inc on Nov 30, 2023 in Conshohocken, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 30, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Conshohocken, PA (United States)
Additional Details
Sponsor, Contract Research Organization